Abbott ViroSeq HIV-1 Genotyping System - Taiwan Registration 2706de7df2f7b20135b49988a9ac7e7a
Access comprehensive regulatory information for Abbott ViroSeq HIV-1 Genotyping System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2706de7df2f7b20135b49988a9ac7e7a and manufactured by ABBOTT MOLECULAR INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2706de7df2f7b20135b49988a9ac7e7a
Ministry of Health Medical Device Import No. 030469
DHA05603046900
Product Details
This product is used to detect the genetic mutation of human immunodeficiency virus (HIV) and to determine whether the virus in the patient has developed resistance to certain antiretroviral drugs to help the monitoring and treatment of HIV infection. The Apevanroxi HIV Genotyping System can be used to: 1. detect resistance to the HIV-1B subtype virus from plasma samples collected using EDTA as an anticoagulant, with viral load detection ranging from 2,000 to 75,000 copies per milliliter (copies/mL). 2. Genotyping codons 1 to 99 of the HIV-1 whole protease gene with codons 1 to 335 of the reverse transcriptase gene (RT).
B Hematology and pathology devices
B4020 Analyze specific reagents
Imported from abroad
Dates and Status
Dec 04, 2017
Dec 04, 2022